Pharmacologic management and prevention of acute pancreatitis
Authors:
- 1 September 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 35 (5) , 460-467
Abstract
The present article will focus in pharmacologic agents that have been studied to improve acute pancreatitis outcomes, and to prevent the disease at different levels. Too little and too much early fluid resuscitation can be harmful. The optimal volume, rate, and duration of intravenous fluid therapy is still unknown. Nonopioid analgesics should be the first line of analgesia in patients with acute pancreatitis. A few pharmacologic agents evaluated in acute pancreatitis have resulted in positive pilot trials; however, larger randomized clinical trials (RCTs) are needed before final conclusions. Statin use is associated with lower incidence of acute pancreatitis in the general population and ongoing studies are evaluating its preventive role in acute pancreatitis recurrences. The preventive role of rectal indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis is indisputable, with subject selection and timing of administration requiring further investigation. There is still no proven effective disease-specific pharmacologic therapy that changes the natural history of acute pancreatitis. New therapeutic targets and pharmacologic agents are in the horizon. Careful refinement in study design is needed when planning future RCTs. There is also a need for drug development aiming at reducing the incidence of the disease and preventing its sequelae.Keywords
This publication has 77 references indexed in Scilit:
- Continuous regional arterial infusion for acute pancreatitis: a propensity score analysis using a nationwide administrative databaseCritical Care, 2013
- A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP PancreatitisNew England Journal of Medicine, 2012
- Present and future of prophylactic antibiotics for severe acute pancreatitisWorld Journal of Gastroenterology, 2012
- Early Fluid Resuscitation Reduces Morbidity Among Patients With Acute PancreatitisClinical Gastroenterology and Hepatology, 2011
- The Results of Severe Acute Pancreatitis Treatment With Continuous Regional Arterial Infusion of Protease Inhibitor and AntibioticPancreas, 2010
- APCAP - activated protein C in acute pancreatitis: a double-blind randomized human pilot trialCritical Care, 2010
- Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitisGut, 2007
- Statins and the risk of acute pancreatitis: a population‐based case–control studyAlimentary Pharmacology & Therapeutics, 2005
- Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitisGut, 2001
- A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitisGut, 1999